Better Response, Survival in Head and Neck Cancer With Dual Pre-Op Immunotherapy

MedPage Today) — Two neoadjuvant immunotherapy combinations for head and neck cancer substantially increased the response rate versus a single drug, a small randomized trial showed.
The pathologic tumor response (pTR) rate increased from 41…